Searched for: school:SOM
Department/Unit:Otolaryngology
Medicin-induceret spytkirteldysfunktion og subjektiv sialore : et systematisk review sponsoreret af the World Workshop on Oral Medicine VI
Wolff, Andy; Joshi, Revan Kumar; Ekstrom, Jorgen; Aframian, Doron; Pedersen, Anne Marie Lynge; Proctor, Gordon; Narayana, Nagamani; Villa, Alessandro; Si, Ying Wai; Aliko, Ardita; McGowan, Richard; Kerr, Ross; Jesne, Siri Beier; Vissink, Arjan
A guide to medications inducing salivary gland dysfunction, xerostomia and subjective sialorrhea: A systematic review sponsored by the World Workshop on Oral Medicine VI Background – Medication-induced salivary gland dysfunction (MISGD), xerostomia (sensation of oral dryness) and subjective sialorrhea cause significant morbidity and impair quality of life. However, evidence-based lists of medications that cause these disorders do not exist. Objective – To compile a list of medications affecting salivary gland function and inducing xerostomia or subjective sialorrhea. Data Sources – Electronic databases were searched for relevant articles published until June 2013. Data Synthesis – A total of 269 papers out of a total of 3867 screened records had an acceptable degree of relevance, quality of methodology and strength of evidence. We found 56 chemical substances with higher level of evidence and 50 with a moderate level of evidence of causing the above mentioned disorders. At the first level of the Anatomical Therapeutic Chemical classification system (ATC), 9 out of 14 anatomical groups were represented, mainly the alimentary, cardiovascular, genitourinary, nervous and respiratory systems. Management strategies include substitution or discontinuation of medications whenever possible, oral or systemic therapy with sialogogues, administration of saliva substitutes, and use of electro-stimulating devices. Limitations – While xerostomia was a commonly reported outcome, objectively measured salivary flow rate was rarely reported. Moreover, xerostomia was mostly assessed as an adverse effect rather than the primary outcome of medication use. This study may not include some medications that could cause xerostomia when given in conjunction with others or for which xerostomia as an adverse reaction has not been reported in the literature or not detected in our search. Conclusions – A comprehensive list of medications having documented effects on salivary gland function or symptoms was compiled, which may assist practitioners in assessing patients who complain of dry mouth while taking medications. The list may also prove useful for anticipating adverse effects and help practitioners to consider alternative medications
ORIGINAL:0012310
ISSN: 0039-9353
CID: 2768702
T2-FLAIR Mismatch, an Imaging Biomarker for IDH and 1p/19q Status in Lower Grade Gliomas: A TCGA/TCIA Project
Patel, Sohil H; Poisson, Laila M; Brat, Daniel J; Zhou, Yueren; Cooper, Lee; Snuderl, Matija; Thomas, Cheddhi; Franceschi, Ana M; Griffith, Brent; Flanders, Adam; Golfinos, John G; Chi, Andrew S; Jain, Rajan
PURPOSE: Lower grade gliomas (WHO grade II/III) have been classified into clinically-relevant molecular subtypes based on IDH and 1p/19q mutation status. The purpose was to investigate whether T2/FLAIR MRI features could distinguish between lower grade glioma molecular subtypes
Experimental Design: MRI scans from the TCGA/TCIA lower grade glioma database (n=125) were evaluated by 2 independent neuroradiologists to assess: 1) presence/absence of homogenous signal on T2WI; 2) presence/absence of "T2-FLAIR mismatch" sign; 3) sharp or indistinct lesion margins; 4) presence/absence of peritumoral edema. Metrics with moderate-substantial agreement underwent consensus review, and were correlated with glioma molecular subtypes. Somatic mutation, DNA copy number, DNA methylation, gene expression, and protein array data from the TCGA lower grade glioma database were analyzed for molecular-radiographic associations. A separate institutional cohort (n=82) was analyzed to validate the T2-FLAIR mismatch sign.
Results: Among TCGA/TCIA cases, inter-reader agreement was calculated for lesion homogeneity (k=0.234 [0.111-0.358]), T2-FLAIR mismatch sign (k=0.728 [0.538-0.918]), lesion margins (k=0.292 [0.135-0.449]), and peritumoral edema (k=0.173 [0.096-0.250]). All 15 cases that were positive for the T2-FLAIR mismatch sign were IDH-mutant, 1p/19q-non-codeleted tumors (p<0.0001; PPV=100%, NPV=54%). Analysis of the validation cohort demonstrated substantial inter-reader agreement for the T2-FLAIR mismatch sign (k=0.747 [0.536 - 0.958]); all 10 cases positive for the T2-FLAIR mismatch sign were IDH-mutant, 1p/19q non-codeleted tumors (p<0.00001; PPV=100%, NPV=76%).
Conclusion: Among lower grade gliomas, T2-FLAIR mismatch sign represents a highly specific imaging biomarker for the IDH-mutant, 1p/19q-non-codeleted molecular subtype.
PMID: 28751449
ISSN: 1078-0432
CID: 2647482
Radiation Therapy Dose and Survival Outcomes in Human Papillomavirus (HPV)-Positive Oropharyngeal Cancer [Meeting Abstract]
Tam, M; Wu, P; Gerber, NK; Schreiber, D; Givi, B; Hu, KS
ISI:000411559103062
ISSN: 1879-355x
CID: 2767292
Intensity Modulated Radiation Therapy With Concurrent Chemotherapy for Larynx Preservation in Locally Advanced Larynx Cancer: A National Cancer Database Study [Meeting Abstract]
Wu, SPP; Tam, M; Shaikh, F; Schreiber, D; Gerber, NK; Givi, B; Hu, KS
ISI:000411559103079
ISSN: 1879-355x
CID: 2767282
The Impact of Adjuvant Chemoradiation Timing on Survival of Head and Neck Cancers [Meeting Abstract]
Tam, M; Wu, P; Gerber, NK; Schreiber, D; Givi, B; Hu, KS
ISI:000411559103061
ISSN: 1879-355x
CID: 2767422
A DNA Methylation-Based Classifier for Accurate Molecular Diagnosis of Bone Sarcomas [Meeting Abstract]
Cooper, BT; Wu, SP; Bu, F; Bowman, CJ; Killian, JK; Serrano, J; Wang, S; Gorovets, D; Gorlick, RG; Ladanyi, M; Thomas, K; Snuderl, M; Karajannis, MA
ISI:000411559104225
ISSN: 1879-355x
CID: 2766742
Patterns of Care and Outcomes of Adjuvant Therapy for High Risk Head and Neck Cancer After Surgery [Meeting Abstract]
Osborn, VW; Givi, B; Roden, DF; Katsoulakis, E; Sheth, N; Lederman, AJ; Schwartz, D; Schreiber, D
ISI:000411559103033
ISSN: 1879-355x
CID: 2766862
Intensity modulated radiation therapy improves survival in early-stage supraglottic larynx cancer [Meeting Abstract]
Wu, S P P; Cohen, P; Tam, M; Schreiber, D; Gerber, N K; Givi, B; Hu, K S
Purpose/Objective(s): Early stage supraglottic larynx cancers treated with definitive radiotherapy (RT) require treatment of the bilateral neck because of high rates of regional spread. Compared to older techniques, modern intensity modulated radiation therapy (IMRT) has been shown to precisely target tumor and draining nodal regions with the potential to spare organs at risk including those essential for prevention of aspiration. However, previous hospital-based studies have demonstrated decreased survival associated with the use of IMRT compared to 3D and 2D radiotherapy techniques in glottic larynx. We used the National Cancer Data Base (NC
EMBASE:618559676
ISSN: 0360-3016
CID: 2752282
The Novel Anti-CD40 Monoclonal Antibody CFZ533 Shows Beneficial Effects in Patients with Primary Sjogren's Syndrome: A Phase IIa Double-Blind, PlaceboControlled Randomized Trial [Meeting Abstract]
Wu, SPP; Cohen, P; Tam, M; Schreiber, D; Gerber, NK; Givi, B; Hu, KS
ISI:000411559103080
ISSN: 2326-5205
CID: 2767272
A Comparison of IMRT and VMAT Treatment Planning for Head and Neck Cancer With NTCP/TCP Analysis [Meeting Abstract]
Kryger, M; Wang, W; Wu, SPP; Xue, J; Cheng, P; Das, IJ; Hu, KS
Food and beverage marketing contributes to poor dietary choices among adults and children. As consumers spend more time on the Internet, food and beverage companies have increased their online marketing efforts. Studies have shown food companies' online promotions use a variety of marketing techniques to promote mostly energy-dense, nutrient-poor products, but no studies have compared the online marketing techniques and nutritional quality of products promoted on food companies' international websites. For this descriptive study, we developed a qualitative codebook to catalogue the marketing themes used on 18 international corporate websites associated with the world's three largest fast food and beverage companies (i.e. Coca-Cola, McDonald's, Kentucky Fried Chicken). Nutritional quality of foods featured on those websites was evaluated based on quantitative Nutrient Profile Index scores and food category (e.g. fried, fresh). Beverages were sorted into categories based on added sugar content. We report descriptive statistics to compare the marketing techniques and nutritional quality of products featured on the company websites for the food and beverage company websites in two high-income countries (HICs), Germany and the United States, two upper-middle-income countries (UMICs), China and Mexico, and two lower-middle-income countries (LMICs), India and the Philippines. Of the 406 screenshots captured from company websites, 67.8% depicted a food or beverage product. HICs' websites promoted diet food or beverage products/ healthier alternatives (e. g. baked chicken sandwich) significantly more often on their pages (25%), compared to LMICs (14.5%). Coca-Cola featured diet products significantly more frequently on HIC websites compared to LMIC websites. Charities were featured more often on webpages in LMICs (15.4%) compared to UMICs (2.6%) and HICs (2.3%). This study demonstrates that companies showcase healthier products in wealthier countries and advertise their philanthropic activities in lower income countries, which is concerning given the negative effect of nutrition transition (double burden of overnutrition and undernutrition) on burden of non-communicable diseases and obesity in lower income countries.
ISI:000411559105194
ISSN: 1879-355x
CID: 2767162